Abstract
In June 2022, the Supreme Court of the United States (US) overturned the right established in Roe v. Wade to terminate a pregnancy. Subsequently, some states passed abortion ban laws prohibiting the use of abortive methods, including methotrexate (MTX), which has been a cornerstone drug in rheumatology. We aimed to explore and analyze Twitter data to comprehend the short-term implications of the overturn on rheumatology care. We conducted a mixed methods study using social media (SoMe) data. Tweets publicly posted using “#Methotrexate or Methotrexate” were tracked. A combination of SoMe performance data with qualitative hashtag co-occurrence analysis and content analysis was conducted. A total of 5180 posts were generated and reached approximately 40 million users. Seventy-three percent of all publications came from the US. Females posted more than males. Additionally, the three pairs of hashtags with higher co-occurrence were: #roevswade, #abortionishealthcare, and #rheumatoidarthritis. From the content analysis, three main themes were generated: (i) violence against women, (ii) health policy without public health intelligence, and (iii) call for strategic alliances in favor of public health. The combination of biological sex and state of residence could condition the use of MTX. Men will be able to continue their treatment; however, women could lose continuity of it. Inequity in access to treatment is a political decision, just as it is to reproduce inequities and vulnerabilities through the actions taken. Not having access to MTX for rheumatic and musculoskeletal diseases (RMDs) is a critical issue that endangers the physical and mental health of people with RMDs.
Similar content being viewed by others
Data availability
The secondary data used in this study are public, published by users with public accounts on the SoMe platform Twitter (http://www.twitter.com).
References
Wade R (1973) 410 US 113
Press, T.A. (2022) Abortion ruling prompts variety of reactions from states. The Associated Press
Zhang J et al (2022) Medical methods for first trimester abortion. Cochrane Database Syst Rev 5(5):Cd0028555
Chan ES, Cronstein BN (2010) Methotrexate—how does it really work? Nat Rev Rheumatol 6(3):175–178
Jukes T (1978) The history of methotrexate. Cutis 21(3):396–398
Aickara D et al (2022) Topical methotrexate in dermatology: a review of the literature. J Dermatol Treat 33(1):512–517
García-González CM, Baker J (2022) Treatment of early rheumatoid arthritis: methotrexate and beyond. Curr Opin Pharmacol 64:102227
Johnson CM, Dassopoulos T (2018) Update on the use of thiopurines and methotrexate in inflammatory bowel disease. Curr Gastroenterol Rep 20(11):1–8
Chung SA et al (2021) 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 73(8):1366–1383
Hahn BH et al (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 64(6):797–808
Fraenkel L et al (2021) 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108–1123
Singh JA et al (2019) 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol 71(1):5–32
Giollo A, Fuzzi E, Doria A (2022) Methotrexate in early rheumatoid arthritis: is the anchor drug still holding? Autoimmun Rev 21(4):103031
Rheumatology TL (2022) The demise of Roe v Wade: ramifications for rheumatology. Lancet Rheumatol 4(8):e525. https://doi.org/10.1016/S2665-9913(22)00189-8
Negrón JB (2019) # EULAR2018: the annual European congress of rheumatology—a twitter hashtag analysis. Rheumatol Int 39(5):893–899
Mcneill A, Burke S (2021) Social media data. In: Lyons E, Coyle A (eds) Analysing qualitative data in psychology. SAGE, pp 83–99
Wang R, Liu W, Gao S (2016) Hashtags and information virality in networked social movement: examining hashtag co-occurrence patterns. Online Inf Rev 40(7):850–866
Simpson E (2018) Integrated & alone: The use of hashtags in Twitter social activism. In: Companion of the 2018 ACM conference on computer supported cooperative work and social computing
Brown ME, Dueñas AN (2020) A medical science educator’s guide to selecting a research paradigm: building a basis for better research. Med Sci Educator 30(1):545–553
Quan-Haase A, Sloan L (2017) Introduction to the handbook of social media research methods: goals, challenges and innovations. In: Quan-Haase A, Sloan L (eds) The SAGE handbook of social media research methods. SAGE, pp 1–9
Ferrara E et al (2016) The rise of social bots. Commun ACM 59(7):96–104
Himelein-Wachowiak M et al (2021) Bots and misinformation spread on social media: implications for COVID-19. J Med Internet Res 23(5):e26933
Pozzana I, Ferrara E (2020) Measuring bot and human behavioral dynamics. Front Phys:125
Flick U (2014) Thematic coding and content analysis. In: SAGE (ed) An introduction to qualitative research. SAGE, pp 420–438
Saldaña J (2021) The coding manual for qualitative researchers. SAGE. pp 1–440
Bermas BL (2022) The unintended consequence of the overturn of Roe v Wade: restrictions on methotrexate use. J Rheumatol 49(11):1284–1285
Dean B (2022) How many people use Twitter in 2022? [New Twitter Stats]
Cohen SB et al (2022) Impact of methotrexate discontinuation, interruption, or persistence in US patients with rheumatoid arthritis initiating tofacitinib + oral methotrexate combination. Clin Ther 44(7):982–997
Xu J et al (2022) Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum 55:152031
Arnold S et al (2022) Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors. Rheumatology 61(1):131–138
Ritschl V et al (2020) Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. RMD Open 6(3):e001432
Callard F, Perego E (2021) How and why patients made long Covid. Soc Sci Med 268:113426
Davis CA et al (2016) Botornot: a system to evaluate social bots. In: Proceedings of the 25th international conference companion on world wide web
Institute's, T.G. Interactive map: US abortion policies and access after Roe. 2023 [cited 2023 June]. Available from: https://states.guttmacher.org/policies/
Acknowledgements
To María Piedad Rosario (medical librarian) for obtaining the full-texts to review the existing literature.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No funding was received for the completion of this research project. However, JBN has received personal grants from the European Alliance of Associations for Rheumatology (EULAR) for activities unrelated to this work. Additionally, he is member of the Outcome Measures in Rheumatology (OMERACT). He has also worked as research fellow in the patient outcomes in longitudinal studies working group of OMERACT.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Negrón, J.B., Rodriguez-Malavé, M.J., Camacho, C.O. et al. The overturn of Roe v. Wade beyond abortion: a snapshot of methotrexate accessibility for people with rheumatic and musculoskeletal diseases—a mixed methods study using Twitter data. Rheumatol Int 43, 2293–2301 (2023). https://doi.org/10.1007/s00296-023-05407-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-023-05407-1